The silver lining is that this pandemic has taught us the importance of biotech in our society’s well being. Biotech firms are engaged in global race of releasing the first coronavirus vaccine. With China’s Sinovac having reportedly reached the later stages of the human trial to Moderna, AstroZeneca and Covaxin, they all are competing to pass trials and reach the final stage.